Joshua Fieggen
Research Assitant
Biography
Josh is a research assistant in the PSI working on emerging infections in the epidemic diseases clinical research group (ERGO). He mostly works supporting Dr Amanda Rojek’s work on developing a global harmonised trial for the treatment of filoviruses (such as Ebola and Marburg). At the PSI he also researches emerging pathogen eradication, and clinical host responses to high consequence pathogens.
Josh has a background as a medical doctor from South Africa. He completed his MBChB and MPH at the University of Cape Town and has previous experience in HIV care and research. He is currently undertaking a DPhil in machine learning for biomarker discovery in the Computational Health Informatics Lab in the Department of Engineering Sciences and is funded by a Rhodes Scholarship.
Key publications
-
Ebola disease: bridging scientific discoveries and clinical application
Rojek A. et al, (2025), The Lancet Infectious Diseases, 25, e165 - e176
-
Utility of a Machine-Guided Tool for Assessing Risk Behaviour Associated with Contracting HIV in Three Sites in South Africa: A field evaluation (Preprint)
Majam M. et al, (2022)
-
Dysregulated Immune Proteins in Plasma in the UK Biobank Predict Multiple Myeloma 12 years Before Clinical Diagnosis
Fieggen J. et al, (2025)
Recent publications
-
Ebola disease: bridging scientific discoveries and clinical application
Rojek A. et al, (2025), The Lancet Infectious Diseases, 25, e165 - e176
-
Dysregulated Immune Proteins in Plasma in the UK Biobank Predict Multiple Myeloma 12 years Before Clinical Diagnosis
Fieggen J. et al, (2025)
-
Ebola disease: bridging scientific discoveries and clinical application.
Rojek A. et al, (2024), The Lancet. Infectious diseases
-
The role of machine learning in HIV risk prediction
Fieggen J. et al, (2022), Frontiers in Reproductive Health, 4
-
Utility of a Machine-Guided Tool for Assessing Risk Behaviour Associated with Contracting HIV in Three Sites in South Africa: A field evaluation (Preprint)
Majam M. et al, (2022)